How Does Acid Affect the Brain’s Function?

LSD, commonly called acid, reshapes brain function primarily by activating serotonin 2A receptors on neurons throughout the cortex, triggering a cascade of changes in how brain networks communicate, filter sensory information, and process emotion. A single dose loosens the normal boundaries between brain regions that usually operate independently, floods sensory areas with internally generated activity, and quiets the default mode network, the circuit most closely tied to your sense of self. These effects emerge within about 30 minutes, peak around two to three hours, and can persist for up to 12 hours, far longer than most other psychedelics with similar receptor targets.

Where LSD Plugs In at the Molecular Level

LSD’s unusual potency and duration trace back to the physical way it fits inside the serotonin 2A receptor. Structural studies have shown that the molecule’s diethylamide group slots into a narrow crevice between specific helical segments of the receptor protein, forming tight nonpolar contacts that anchor it in place.¹ A loop of the receptor called extracellular loop 2, or ECL2, then folds down over the bound LSD molecule like a lid, effectively trapping it inside the binding pocket.² This lid mechanism explains why LSD’s effects last so much longer than those of other serotonin-targeting psychedelics: the drug is physically trapped at the receptor for hours rather than binding and unbinding quickly.

Once locked in, LSD does not simply flip the receptor “on” the way the brain’s own serotonin does. It activates certain downstream signaling pathways more than others, a phenomenon researchers call biased agonism. LSD and several other synthetic psychedelics act as full or near-full agonists at the serotonin 2A receptor’s G protein signaling pathway, while naturally derived compounds like psilocin and DMT behave more like partial agonists.³ At serotonin 2C receptors, psychedelics including LSD show a pronounced bias toward one specific G protein pathway and minimal activation of secondary G protein routes, which may contribute to the distinct quality of the psychedelic state compared to other serotonin-driven experiences.⁴

LSD also interacts with receptors beyond the serotonin system. It has activity at dopamine D1 through D3 receptors, which psilocybin does not share, and this difference likely accounts for some of the subjective distinctions between the two drugs, including LSD’s somewhat more stimulating and longer-lasting quality.⁵

How the Thalamic Gate Opens

Under normal conditions, the thalamus acts as a relay station that filters incoming sensory signals before they reach the cortex. One influential model of psychedelic action, the cortico-striato-thalamo-cortical (CSTC) loop model, proposes that psychedelics disrupt this filter. Imaging studies support the idea: LSD increases the flow of information from the thalamus to higher cortical areas, particularly the posterior cingulate cortex, and this effect depends on serotonin 2A receptor activation. At the same time, LSD decreases signaling from the ventral striatum back to the thalamus through a mechanism that appears independent of the serotonin 2A receptor.⁶

The net result is that sensory information that would normally be screened out before reaching awareness pours through to the cortex. Downstream of the receptor, LSD also triggers a wave of glutamate release in the prefrontal cortex. Electrophysiology in brain slices has shown that both LSD and related psychedelics enhance a prolonged, late surge of glutamate onto deep cortical neurons after stimulation.⁷ This glutamate flood amplifies cortical excitability and may be the proximate mechanism behind many of acid’s perceptual distortions.

Visual Hallucinations and the Eyes-Closed Cinema

The vivid, often geometric visual effects of LSD are among its most recognizable features, and brain imaging has pinpointed how they arise. Under LSD, blood flow to the visual cortex increases, the normal alpha brainwave rhythm that suppresses visual processing drops away, and the primary visual cortex dramatically expands its functional connections with other brain regions. All three of these changes correlate with the intensity of visual hallucinations that participants report.⁸

Even with eyes closed, the visual cortex under LSD behaves as though it is processing real visual input. A study examining resting-state connectivity within early visual areas found that under LSD, the visual cortex’s internal organization became more dependent on its built-in spatial map, the same map it uses to represent real images. The researchers described this as the early visual system acting “as if it were seeing spatially localized visual inputs” when no external visual information was present.⁹ In other words, the brain generates its own visual experience using the same circuits it normally reserves for processing the outside world.

Network Reorganization and Ego Dissolution

Beyond individual brain regions, LSD transforms the way large-scale brain networks talk to each other. Under normal waking conditions, the brain is organized into relatively distinct networks: the default mode network handles self-referential thought, the salience network monitors what deserves attention, and the dorsal attention network focuses on the external environment. These networks typically maintain clear boundaries, sometimes actively inhibiting each other. LSD blurs those boundaries.

Imaging studies show that LSD increases global functional connectivity, particularly in higher-level association cortices, the thalamus, and areas that partially overlap with the default mode, salience, and frontoparietal attention networks. At the same time, the drug inflates communication between networks that are normally distinct. The increase in global connectivity correlated with participants’ reports of ego dissolution, the subjective experience of the boundary between self and world breaking down.¹⁰ Regions where this correlation was strongest included the angular gyrus and the insular cortex, areas associated with self-awareness and body ownership.

A systematic review of psychedelic neuroimaging studies found that decreased integrity and blood flow in the default mode network was a consistent finding across multiple psychedelics, and this disruption correlated with measures of ego dissolution.¹¹ LSD also had a pronounced global effect on brain entropy, increasing it across both sensory and higher-order networks and across multiple time scales, essentially pushing the brain into a less predictable, more flexible state.¹²

When researchers used a brain-wide blocker of the serotonin 2A receptor (ketanserin) before giving LSD, the drug’s ability to increase sensory and somatomotor connectivity was blocked. This confirmed that these network-level changes depend on the same receptor that LSD grips at the molecular level.¹³

Emotional Processing Under LSD

LSD does not just alter perception and the sense of self; it also reshapes how the brain responds to emotional information. In a placebo-controlled study, LSD reduced activity in the amygdala when participants viewed fearful faces, particularly in the left amygdala and right medial prefrontal cortex. Strikingly, the stronger a participant’s overall subjective drug experience, the more their amygdala response to fearful stimuli was dampened.¹⁴

This finding has drawn interest from researchers studying depression and anxiety, where the amygdala is often hyperactive in response to threatening stimuli. The idea that LSD can temporarily quiet the brain’s fear circuitry while simultaneously increasing openness and emotional range may explain the “afterglow” that many users describe in the days following a trip, a period of reduced anxiety and increased well-being.

Structural Changes and Neuroplasticity

One of the more surprising discoveries about psychedelics in recent years is that they promote the physical growth of neurons. In laboratory studies, LSD, psilocin, DMT, and related compounds all increased the branching of neurites (the projections neurons use to communicate) and the density of dendritic spines (the tiny protrusions where synapses form). LSD was particularly potent in this regard, active at concentrations hundreds of times lower than ketamine. In cultured neurons, LSD nearly doubled the number of spines per unit length of dendrite.¹⁵

More recent work has clarified that these growth effects do not depend on the same receptor responsible for the psychedelic experience. LSD and psilocybin promote spine growth by directly binding to TrkB, the receptor for brain-derived neurotrophic factor (BDNF), a key growth signal in the brain. Blocking the serotonin 2A receptor did not prevent the spine-growing effect, but blocking TrkB did, indicating that the plasticity pathway and the hallucinatory pathway are at least partially separable.¹⁶ This separation is a major reason pharmaceutical companies are now trying to develop non-hallucinogenic compounds that retain the plasticity-promoting effects.

Why Tolerance Builds So Quickly

Anyone who has taken LSD on consecutive days knows the effects fade dramatically the second time around. Tolerance to LSD develops rapidly, often within a few days, and takes roughly a week of abstinence to fully reverse. The mechanisms behind this are more complex than a simple receptor count story. In rat studies, repeated LSD administration did reduce serotonin 2A receptor density in cortical regions, consistent with the brain pulling receptors off the surface in response to overstimulation.¹⁷

However, the picture is not that simple. A separate line of research found that LSD tolerance in rats correlated with decreased glutamate receptor binding rather than with serotonin 2A receptor downregulation. This contrasted with another psychedelic (DOI), whose tolerance tracked tightly with serotonin 2A changes. The implication is that tolerance can arise at different levels of the signaling chain depending on the drug: if serotonin 2A receptors do not downregulate sufficiently, the glutamate receptors sitting downstream can adapt instead and effectively throttle the cortical overstimulation.¹⁸

In humans, a single dose of LSD did not change the expression of the gene encoding the serotonin 2A receptor at either 1.5 or 24 hours after administration.¹⁹ So the rapid behavioral tolerance people experience after a single trip likely involves changes in downstream signaling, receptor internalization, or glutamate pathway adaptation rather than a quick rewriting of the genetic blueprint.

Microdosing and What Low Doses Actually Do

The practice of taking very small amounts of LSD, typically between 10 and 25 micrograms, has become widespread despite limited controlled evidence. A rapid review of placebo-controlled microdosing studies found that low doses of LSD did produce measurable changes in brain connectivity, mood, and cognition compared to placebo. Neuroimaging showed altered connectivity across amygdala and cerebellar regions, and EEG studies found reduced default mode network activity and increased neural complexity in patterns resembling what full doses produce, just at smaller magnitudes. Across multiple studies, microdosing LSD consistently increased acute feelings of vigor and energy.²⁰

But the enthusiasm outpaces the evidence. A controlled study giving healthy adults repeated low doses of LSD (13 or 26 micrograms) at three- to four-day intervals found that the higher dose produced modest subjective effects, including feeling stimulated and perceiving a “drug effect,” but did not improve mood or performance on cognitive or emotional tasks. No lasting effects were detected at a drug-free follow-up session. The researchers concluded that repeated low doses of LSD were safe but produced negligible changes in mood or cognition in healthy volunteers.²¹ The gap between microdosing lore and controlled trial results remains one of the most unresolved questions in psychedelic research.

When the Trip Does Not Fully End

For a small minority of users, some of LSD’s perceptual effects persist long after the drug has left the body. Hallucinogen persisting perception disorder, or HPPD, involves ongoing visual disturbances such as halos, trailing images, geometric patterns, or flickering in the visual field. The leading neurobiological theory is that LSD damages or impairs inhibitory interneurons in the visual cortex that use GABA, the brain’s main inhibitory neurotransmitter, to filter out unnecessary visual noise. This damage could leave visual processing circuits chronically disinhibited, allowing irrelevant signals through that the brain would normally suppress.²²²³

HPPD remains poorly understood in part because it is hard to study. It appears to be rare, and there is no reliable way to predict who will develop it. There is no established dose threshold below which it cannot occur, and some case reports describe it after a single use. The condition can resolve on its own within weeks or months, but in some individuals it persists for years. No drug has been approved specifically for its treatment, though benzodiazepines and certain anticonvulsants have shown some benefit in case series by boosting GABAergic inhibition.

Lasting Personality and Psychological Changes

Whether LSD produces durable personality changes outside of the acute experience is a question with mixed answers. A study tracking college students in Germany who used a psychedelic for the first time found small increases in trait openness and small decreases in conscientiousness compared to a matched control group, but these effects were modest and fell short of statistical significance after adjusting for confounders.²⁴

A controlled laboratory study took a more rigorous approach, administering a single dose of LSD to healthy adults and measuring personality traits at one month and twelve months afterward. The researchers found no lasting changes in openness, the trait most commonly linked to psychedelic use in popular accounts. Conscientiousness actually increased at twelve months compared to baseline, which went in the opposite direction from the naturalistic study.²⁵ The discrepancy between controlled and naturalistic findings is a reminder that set, setting, and the broader context of the experience may matter as much as the pharmacology for long-term psychological outcomes.

LSD-Assisted Therapy and White Matter Changes

The clinical frontier for LSD involves not just its acute effects but whether those effects, combined with psychotherapy, can produce lasting benefit for conditions like major depression. Early results from clinical trials are generating cautious optimism. A recent study of LSD-assisted therapy in major depressive disorder found that participants who received a high dose of LSD showed measurable microstructural changes in brain white matter, the insulated cables connecting distant brain regions. Specifically, the integrity of white matter tracts including the internal capsule, external capsule, and pathways connecting the limbic system increased after treatment, and these increases correlated with improvements in depressive symptoms at two, six, and twelve weeks of follow-up.²⁶

These findings are preliminary and come from a small trial, so it would be premature to draw broad conclusions. But the idea that a psychedelic experience, combined with its direct plasticity-promoting effects on neurons, might physically rewire connectivity between brain regions in a way that tracks with clinical improvement is a genuinely novel therapeutic hypothesis. It suggests that the acute experience and the structural changes may work in concert: the trip loosens rigid patterns of thought and network activity, and the subsequent burst of neuroplasticity helps the brain consolidate new patterns rather than snapping back to old ones. Whether this model holds up in larger trials will be one of the defining questions in psychiatry over the coming decade.